期刊文献+

78例肺栓塞的临床特征与诊治 被引量:6

Clinical characteristics and treatment of 78 patients with pulmonary embolism
下载PDF
导出
摘要 目的回顾分析78例肺栓塞病例的临床资料,探讨《急性肺栓塞诊断与治疗中国专家共识(2015)》用于指导肺栓塞临床实践的价值以及注意事项。方法按照《急性肺栓塞诊断与治疗中国专家共识(2015)》的建议,收集2009年1月至2016年3月在我院确诊为肺栓塞的78例病例的易患因素、临床表现、诊断以及治疗方面的信息。结果 72例(92%)患者有肺栓塞易患因素。主要的临床表现为呼吸困难(73%)、胸痛(28%)、咳嗽(24%)、发热(6%)、咯血(3%)、晕厥及晕厥先兆(19%)、单侧肢体疼痛(6%)、单侧肢体肿胀(22%)。辅助检查提示D二聚体增高(96%)、心房利钠肽增高(75%)、心肌钙蛋白增高(61%),超声心动图提示右心负荷增加(53%)。心电图检查示窦性心动过速(46%),I导联S波(47%),右束支传导阻滞或V1~V4T波倒置(39%)。59%病例Wells评分≥2分,50%的病例Geneva评分≥3分,提示可能有肺栓塞。67例患者使用了口服抗凝药治疗,16例患者进行了溶栓治疗。结论肺栓塞的诊疗尚需按照《急性肺栓塞诊断与治疗中国专家共识(2015)》进一步的规范。 Objective To retrospectively analyze the clinical data of 78 patients with pulmonary embolism in order to explore the clinical practice value and notes of "Chinese expert consensus of diagnosis and treatment of acute pulmonary embolism in 2015". Methods We collected the data about susceptible factors ,clinical manifestation ,diagnosis and treatment from 78 patients with pulmo-nary embolism who were diagnosed in our hospital between January 2009 and March 2016 according to suggestions of the expert consen-sus.Results Seventy-two patients (92%) had risk factors for pulmonary embolism .The main clinical manifestations were dyspnea (73%),chest pain (28%),cough (24%),fever (6%),hemoptysis (3%),syncope and presyncope (19%),unilateral limb pain (6%),and single limb swelling (22%).Laboratory tests showed elevated D-dimer (96%),BNP (75%) and cardiac troponin (61%).Echocardiogram showed an increase of right heart load (53%).ECG showed sinus tachycardia (46%),SⅠ(47%),and right bundle branch block or V1 ~V4 T wave inversion (39%).There were 59%of cases with the Wells score ≥2 points and 50%of ca-ses with Geneva score ≥3 points,suggesting pulmonary embolism .There were 67 patients treated with oral anticoagulant therapy and 16 patients undergone thrombolytic therapy .Conclusion The diagnosis and treatment of pulmonary embolism need to follow "Chinese ex-pert consensus of diagnosis and treatment of acute pulmonary embolism in 2015" for further improvements .
作者 朱平 陈霞 柴虹 舒茂琴 宋治远 ZHU Ping CHEN Xia CHAI Hong SHU Mao-qin SONG Zhi-yuan(Department o f Cardiovascular Diseases, Southwest Hospital, The Third Military Medical University, Chongqing 400038, Chin)
出处 《实用医院临床杂志》 2017年第2期58-61,共4页 Practical Journal of Clinical Medicine
关键词 肺栓塞 静脉血栓栓塞症 临床表现 Pulmonary embolism Venous thromboembolism Clinical manifestations
  • 相关文献

参考文献3

二级参考文献98

  • 1胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 2邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 3Hirsh J, Fuster V, Ansell J, et al. American Heart Association/ American College of Cardiology Foundation guide to warfarin therapy. J Am Coil Cardiol, 2003,41:1633-1652.
  • 4Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007, 146:S57-867.
  • 5Hu D, Sun Y. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China. J Am Coil Cardiol, 2008, 52: 865-868.
  • 6Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med, 2005,352:2285-2293.
  • 7Aithal GP, Day CP, Kesteven PJ, et al. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet, 1999, 353:717-719.
  • 8Ageno W, Gallus AS, Wittkowsky A, et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141 (2 Suppl) :eddS- 88S.
  • 9Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141 (2 Suppl) :e152S-184S.
  • 10Manolopoulos VG, Ragia G, Tavridou A. Pharmacogenetics of coumarinic oral anticoagulants. Pharmacogenomics, 2010, 11 : 493 -496.

共引文献1200

同被引文献59

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部